Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?
about
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidenceInterstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapyBladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.Hemorrhagic cystitis: A challenge to the urologist.Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndromeDecrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine useThe role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease.Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective studyThe clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections.Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study.Pharmacokinetic considerations for therapies used to treat interstitial cystitis.Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions.The use of intravesical hyaluronic acid for recurrent urinary tract infections in children: a case-series study.[Urethral pain syndrome: fact or fiction--an update].Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.[Prophylaxis of recurrent urinary tract infections].Interstitial cystitis: an enigmatic disorder of unclear aetiology.Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis.A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results.Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.[Treatment of long-term radiation injuries in the urinary tract].Intravesical instillations for the treatment of refractory recurrent urinary tract infections.Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications
P2860
Q26749098-5C4F11BE-9952-4936-85FB-AE95ECE2139AQ26773545-C78ABC6D-1E2B-4AB7-BA72-01CCB65AB873Q33667193-BFE4ED11-B84B-4BB7-8E27-FF2907818D71Q34123974-B2D9462E-44BC-44E1-B387-E310A0C05A4CQ34267531-C8CBB6C5-6572-43AE-AD11-E045D964C11BQ35116670-FB017245-73CA-4514-B634-CB74F13BB2A0Q35200052-CB9EE00E-5326-4E83-94D5-A0AC7C3156DCQ35424968-69033B51-8112-487E-83F8-C35CC3EFAA08Q37040772-162931A4-1FDB-48F3-B174-E250375DA277Q37198151-85163068-3595-4A27-9F2D-0BC96AB6D07AQ37300937-BF466774-F2A0-4F58-AF70-5651148F25C5Q38195318-50A2EE04-70C6-4A68-A57D-456C54DAA6ADQ38196864-237E4FEE-97BE-40E4-8ED7-7E2AF7D37D2BQ39069615-05D44030-4AC1-46FE-A0A4-8064BE90DF01Q40111907-0CEA3277-DA29-4AE3-958D-6F15D1E835E7Q40997105-67283A74-10D5-419B-9BAA-550FF9D39368Q41017332-8CE249D0-C6AF-45E4-B52B-0439013C8905Q41384895-1662EEA3-02C5-4E22-A695-8F363C26A707Q41712298-E8CFAD1A-6C74-4242-ADEB-3CB3AFA4917EQ42336247-63CD2050-A77D-42FE-A57F-860C26094D96Q43700926-4D1E1E42-8A93-49FE-94BD-F682D51779E2Q47147327-24CD54FB-9709-4AF5-AA8F-81C5C34DA449Q47572129-55E29549-9A47-400D-8B58-4C80F928FC42Q47655818-8886A0A6-F12E-44DD-8D96-2C7606673134Q48445212-A2632A32-22CB-438F-9CD7-897217DD627DQ48966330-6443064C-F69D-4822-8A5B-4E385348EA34Q53236476-FC322DE4-A981-496F-8E25-67B58D62E59DQ54240864-EB638C5D-6163-41F3-B607-EF3033D2E100Q58484641-434C0B31-B025-45B3-92F9-A761CFD7B36A
P2860
Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@ast
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@en
type
label
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@ast
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@en
prefLabel
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@ast
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@en
P1433
P1476
Hyaluronic acid: an effective ...... ons, and hemorrhagic cystitis?
@en
P2093
Christos Iavazzo
Eleni Pitsouni
P304
1534-40; discussion 1540-1
P356
10.1016/J.EURURO.2007.03.020
P407
P577
2007-03-20T00:00:00Z